Mutex raises ¥281.6M in Series A funding to expand its AI-powered medical billing SaaS, Reze, with participation from MTI Co., Ltd., MEDIPAL Innovation Investment Limited Partnership, and Nippon Management Co., Ltd.
Mutex, a Tokyo-based health-tech startup specializing in medical claims processing automation, has raised 281.6 million yen in a Series A funding round. This latest investment will be used to expand the adoption of its AI-powered medical billing SaaS, Reze, among medical institutions. Funds will also support product development for the complete automation of medical claims processing workflows. Mutex's innovative solutions aim to reduce administrative burdens and improve operational efficiency in healthcare facilities.
Company Information
Company
Mutex
Location
Bunkyo, Tokyo, Japan
About
Mutex is a software development company focused on AI-powered solutions for medical institutions. Its flagship product, Reze, is a SaaS platform designed to help medical institutions automate claim processing and improve operational management. By leveraging generative AI and machine learning, Reze simplifies administrative tasks and optimizes revenue for medical departments. Founded in 2022 and headquartered in Tokyo, Japan, Mutex aims to drive digital transformation in the healthcare sector.
Fundz sees it the moment Mutex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.